药 物 回 收
|
| |
| The United Kingdom: Class 2 Medicines Recall: Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml) (English only) |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that Curaleaf Laboratories are recalling 3 batches of Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml) (delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)) (batch number: B11/01/24-30, B11/04/24-30, B11/05/24-30) due to low THC content. Curaleaf Laboratories have informed MHRA of a confirmed stability study failure where the THC content is below the acceptable level in Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml). The above batches of Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml) are being recalled out of an abundance of caution.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-2-medicines-recall-rokshaw-limited-trading-as-curaleaf-laboratories-curaleaf-oil-fs-10mg-slash-ml-thc-10mg-slash-ml-cbd-30ml-el-26-a-slash-13
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Friday, Mar 13, 2026
Issued at HKT 16:15
|
| |
